[1] Pilipchuk SP, Plonka AB, Monje A, et al.Tissue engineering for bone regeneration and osseointeration in the oral cavity[J]. Dent Mater, 2015, 31(4): 317-338. [2] 谢程欣, 余城墙, 王维, 等. 骨形态发生蛋白与自体骨移植治疗四肢长骨骨不连的 Meta 分析[J]. 中国组织工程研究,2020,24(5): 803-810. [3] 郭敏, 刘林, 胡征. 外源性成纤维细胞生长因子联合引导骨再生术在前牙种植修复中对种植区骨量、种植体周围炎的影响[J]. 四川医学, 2019, 40(8): 803-806. [4] Schliephake H.Clinical efficacy of growth factors to enhance tissue repair in oral and maxillofacial reconstruction: a systematic review[J]. Clin Implant Dent Relat Res, 2015, 17(2): 247-273. [5] Smith PC, Martínez C, Cáceres M, et al.Research on growth factors in periodontology[J]. Periodontol 2000, 2015, 67(1): 234-250. [6] Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling[J].J Clin Invest,1988, 81(2): 277-281. [7] Hauschka PV, Mavrakos AE, Iafrati MD, et al.Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose[J]. J Biol Chem, 1986, 261(27): 12665-12674. [8] Heldin CH, Johnsson A, Wennergren S, et al.A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains[J]. Nature, 1986, 319(6053): 511-514. [9] Saygin NE, Tokiyasu Y, Giannobile WV, et al.Growth factors regulate expression of mineral associated genes in cementoblasts[J]. J Periodontol, 2000, 71(10): 1591-1600. [10] Cheng H, Jiang W, Phillips FM, et al.Osteogenic activity of the fourteen types of human bone morphogenetic proteins(BMPs)[J]. J Bone Joint Surg Am, 2003, 85(8): 1544-1552. [11] Trombelli L, Farina R.Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration[J].J Clin Periodontol, 2008, 35(8 Suppl): 117-135. [12] Garg P, Mazur MM, Buck AC, et al.Prospective review of mesenchymal stem cells differentiation into osteoblasts[J]. Orthop Surg, 2017, 9(1): 13-19. [13] 闫巍. 成纤维细胞生长因子联合引导骨再生术在双尖牙区即刻种植中的应用[J].实用临床医药杂志, 2017, 21(3): 153-155. [14] Murakami S.Periodontal tissue regeneration by signaling molecule(s): what role does basic fibroblast growth factor (FGF-2) have in periodontal therapy?[J]. Periodontology 2000, 2011, 56(1): 188-208. [15] 金晓明, 陶海彪, 江银华. 间充质干细胞相关生长因子在牙槽骨修复的应用进展[J].口腔医学, 2019, 39(1): 66-70. [16] 周洪, 王小波, 束嫘. CGF在颌骨囊肿手术中的应用价值[J]. 全科口腔医学杂志, 2017, 4(17): 47-49. [17] Hu K, Olsen BR.Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair[J]. J Clin Invest, 2016, 126(2): 509-526. [18] Wang F, Li Q, Wang Z.A comparative study of the effect of bio-Oss in combination with concentrated growth factors or bone marrow-derived mesenchymal stem cells in canine sinus grafting[J]. J Oral Pathol Med, 2017, 46(7): 528-536. [19] Corinaldesi G, Piersanti L, Piattelli A, et al.Augmentation of the floor of the maxillary sinus with recombinant human bone morphogenetic protein-7:a pilot radiological and histological study in humans[J]. Br J Oral Maxillofac Surg, 2013, 51(3): 247-252. [20] Nevins M, Kirker-Head C, Nevins M, et al.Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2[J]. Int J Periodontics Restor Dent,1996,16(1): 8-19. [21] Liu Y, Enggist L, Kuffer AF, et al.The inflfluence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration[J]. Biomaterials, 2007, 28(16): 2677-2686. [22] Choi Y, Lee JS, Kim YJ, et al.Recombinant human bone morphogenetic protein-2 stimulates the osteogenic potential of the Schneiderian membrane: a histometric analysis in rabbits[J]. Tissue Eng Part A, 2013, 19(17-18): 1994-2004. [23] Cha JK, Lee JS, Kim MS, et al.Sinus augmentation using BMP-2 in a bovine hydroxyapatite/collagen carrier in dogs[J]. J Clin Periodontol, 2014, 41(1): 86-93. [24] Triplett RG, Nevins M, Marx RE,et al.Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation[J]. J Oral Maxillofac Surg, 2009, 67(9): 1947-1960. [25] Lokwani BV, Gupta D, Agrawal RS, et al.The use of concentrated growth factor in dental implantology: a systematic review[J]. J Indian Prosthodont Soc, 2020, 20(1): 3-10. [26] Stefani CM, Machado MA, Sallum EA, et al.Platelet-derived growth factor/insulin-like growth factor-1 combination and bone regeneration around implants placed into extraction sockets: a histometric study in dogs[J]. Implant Dent, 2000, 9(2): 126-131. [27] Jung RE, Glauser R, Schärer P, et al.Effect of rhBMP-2 on guided bone regeneration in humans[J]. Clin Oral Implants Res, 2003, 14(5): 556-568. [28] Jung RE, Windisch SI, Eggenschwiler AM, et al.A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2[J]. Clin Oral Implants Res, 2009, 20(7): 660-666. [29] Schropp L, Wenzel A, Kostopoulos L, et al.Bone healing and soft tissue contour changes following single-tooth extraction[J]. Int J Periodontics Restorative Dent, 2003, 23(4): 313-323. [30] McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2(INFUSE Bone Graft)[J]. Int Orthop,2007,31(6): 729-734. [31] Shim JY, Lee Y, Lim JH, et al.Comparative evaluation of recombinant human bone morphogenetic protein-2/hydroxyapatite and bovine bone for new bone formation in alveolar ridge preservation[J]. Implant Dent, 2018, 27(6): 623-629. [32] Araújo MG, da Silva JCC, de Mendonça AF, et al. Ridge alterations following grafting of fresh extraction sockets in man: a randomized clinical trial[J]. Clin Oral Implants Res, 2015, 26(4): 407-412. [33] Cardaropoli D.Vertical ridge augmentation with the use of recombinant human platelet-derived growth factor-BB and bovine bone mineral: a case report[J]. Int J Periodontics Restorative Dent, 2009, 29(3): 289-295. [34] Sohn B, Hwang M, Kim S, et al.Ridge preservation using basic fibroblast growth factor-2 and collagenated biphasic calcium phosphate in beagle dogs[J]. J Periodontal Implant Sci, 2017, 47(6): 381-387. [35] Isler SC, Soysal F, Ceyhanl T, et al.Regenerative surgical treatment of peri-implantitis using either a collagen membrane or concentrated growth factor: a 12-month randomized clinical trial[J]. Clin Implant Dent Relat Res, 2018, 20(5): 703-712. [36] Froum SJ, Froum SH, Rosen PS.Successful management of peri-implantitis with a regenerative approach: a consecutive series of 51 treated implants with 3-to 7.5-year follow-up[J]. Int J Periodontics Restorative Dent, 2012, 32(1): 11-20. [37] Shyu SS, Fu E, Shen EC.Clinical and microcomputed topography evaluation of the concentrated growth factors as a sole material in a cystic bony defect in alveolar bone followed by dental implantation: a case report[J]. Implant Dent, 2016, 25(5): 707-714. [38] 郭雪生, 王建国. 浓缩生长因子联合同种异体骨颗粒及人工膜治疗牙源性颌骨囊肿的疗效观察[J].中国临床医生杂志, 2019, 47(3): 331-333. [39] 李伯友, 苏铭扬, 李阳, 等. CGF联合骨代用品及口腔修复膜在颌骨囊肿手术中的应用[J].临床口腔医学杂志, 2016, 32(8): 476-478. [40] 魏中武, 黄谢山, 陈灼庚. 浓缩生长因子在口腔临床中的应用及研究进展[J]. 国际口腔医学杂志, 2020, 47(2): 235-242. [41] Raja S, Byakod G, Pudakalkatti P.Growth factors in periodontal regeneration[J]. Int J Dent Hyg, 2009, 7(2): 82-89. [42] An S, Huang X, Gao Y, et al.FGF-2 induces the proliferation of human periodontal ligament cells and modulates their osteoblastic phenotype by affecting Runx2 expression in the presence and absence of osteogenic inducers[J]. Int J Mol Med, 2015, 36(3): 705-711. [43] Howell TH, Fiorellini JP, Paquette DW, et al.A phase Ⅰ/Ⅱ clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-Ⅰ in patients with periodontal disease[J]. J Periodontal, 1997, 68(12): 1186-1193. [44] Camelo M, Nevins ML, Schenk RK, et al.Periodontal regeneration in human Class Ⅱ furcations using purified recombinant human platelet-derived growth factor-BB(rhPDGF-BB) with bone allograft[J]. Int J Periodontics Restorative Dent, 2003, 23(3): 213-225. [45] Cochran DL, Oh TJ, Mills MP, et al.A randomized clinical trial evaluating rh-FGF-2/β-TCP in periodontal defects[J]. J Dent Res, 2016, 95(5): 523-530. [46] Yoshinuma N, Koshi R, Kawamoto K, et al.Periodontal regeneration with 0.3% basic fibroblast growthfactor (FGF-2) for a patient with aggressive periodontitis: acase report[J]. J Oral Sci, 2016, 58(1): 137-140. [47] Li F,Yu F,Xin X, et al.Evaluation of recombinant human FGF-2 and PDGF-BB in periodontal regeneration: asystematic review and meta-analysis[J]. Sci Rep,2017,7(1): 65-74. [48] Patel ZS, Young S, Tabata Y, et al.Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model[J]. Bone, 2008, 43(5): 931-940. [49] Gronowicz G, Jacobs E, Peng T, et al.Calvarial bone regeneration is enhanced by sequential delivery of FGF-2 and BMP-2 from layer-by layer coatings with a biomimetic calcium phosphate barrier layer[J]. Tissue Eng Part A, 2017, 23(23-24): 1490-1501. |